Tarsus Pharmaceuticals, Inc. (TARS)
71.52
-1.29
(-1.77%)
USD |
NASDAQ |
Aug 25, 16:00
71.52
0.00 (0.00%)
After-Hours: 19:43
Tarsus Pharmaceuticals Debt to Equity Ratio : 0.2557 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2557 |
| March 31, 2026 | 0.2541 |
| December 31, 2025 | 0.2418 |
| September 30, 2025 | 0.2462 |
| June 30, 2025 | 0.2178 |
| March 31, 2025 | 0.2113 |
| December 31, 2024 | 0.3227 |
| September 30, 2024 | 0.3046 |
| June 30, 2024 | 0.2862 |
| March 31, 2024 | 0.1109 |
| December 31, 2023 | 0.1611 |
| September 30, 2023 | 0.141 |
| June 30, 2023 | 0.1695 |
| March 31, 2023 | 0.1454 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.1048 |
| September 30, 2022 | 0.0992 |
| June 30, 2022 | 0.091 |
| March 31, 2022 | 0.1357 |
| December 31, 2021 | 0.0072 |
| September 30, 2021 | 0.0072 |
| June 30, 2021 | 0.0033 |
| March 31, 2021 | 0.0037 |
| December 31, 2020 | 0.005 |
| September 30, 2020 | 0.0096 |
| June 30, 2020 | 0.0163 |
| March 31, 2020 | |
| December 31, 2019 | 0.0029 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Structure Therapeutics, Inc. | 0.0046 |
| Alumis, Inc. | 0.0806 |
| Veradermics, Inc. | 0.0005 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 611.14M |
| Total Liabilities (Quarterly) | 264.41M |
| Shareholders Equity (Quarterly) | 346.73M |
| Current Ratio | 3.198 |
| Net Debt Paydown Yield | -0.12% |